Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CannaInvestor Magazine is a digital media and investment-focused publication dedicated to the cannabis and hemp industries. The company provides in-depth analysis, company profiles, and market insights to help institutional and individual investors navigate the evolving cannabis landscape. Its offerings include monthly digital magazines, investor presentations, and a platform for cannabis companies to increase their visibility among the investment community. While not a drug developer itself, the magazine serves as a critical information hub for the medical and recreational cannabis sectors, covering regulatory changes and financial trends.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CannaInvestor Magazine.